Skip to main content

LIVE

CTSO

Cytosorbents Corporation

CTSO

NASDAQ·Healthcare·Medical - Devices·Mkt cap $22.0M

$0.35

+0.03%

P/E

-1.22

Mkt Cap

$22.0M

52-Wk Range

$0.34–$20.80

52-Week Range

$0.34 - $20.80

P/E

-1.22

Fwd P/E

-1.59

Beta

1.34

Div Yield

0.00%

Avg Vol

213.6K

Shares Out

62.8M

Mkt Cap

$22.0M

Price action

Price chart

Down 64.4% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary Adsorbent and Porous Polymer Technology Platform
  • Clinical Evidence and Regulatory Approvals Across Multiple Indications
  • First-Mover Advantage in Extracorporeal Cytokine Filtration
  • Diverse Product Pipeline Addressing Multiple Critical Care Applications

Bear Case

1 risk

  • Average volatility.

Growth

Stable outlook

Increasing Sepsis Incidence and Clinical Adoption of CytoSorb Therapy

Value

Deep value opportunity - significant discount to Medical Devices peers

Momentum

Weak

-15.5% over 3m

Quality

Excellent

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Oct 29, 2026

Q3 26 RECAP

AUG 6, 2026

Reported EPS of -$0.07 vs -$0.04 consensus (-75.0% surprise). Revenue of $9.6M vs $9.4M expected (+2.6%).

EPS miss
Rev beat +2.6%

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-75.0%

Revenue trend · last 8Q

-3%

+9%

+10%

+1%

+2%

+0%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$8.6M

$9.2M

$8.7M

$9.6M

$9.5M

$9.2M

$8.9M

$9.6M

Margins · last 8Q

Gross

73.2%

Operating

-27.4%

Profit

-45.9%

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

Latest: D. Boral Capital · Mar 26, 2026

vs Industry

How CTSO stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.